16th August 2019
Project seeks to enhance artificial pancreas (AP) with APplus system
An article recently published in the prestigious “Journal of Diabetes Science and Technology” details how the EIT Health Innovation Project CLOSE is developing an APplus system to enhance the benefits of an artificial pancreas for patients with type 2 diabetes.
The lead author on the article was Freimut Schliess, leader of the CLOSE project. The list of 20 additional co-authors includes Jan-Philipp Beck, CEO of EIT Health, as well as others who either on the EIT Health staff or are active in EIT Health projects.
The full article can be seen online here. A PDF can be downloaded from the link below.
The Abstract of the Article, titled “Artificial Pancreas Systems for People With Type 2 Diabetes: Conception and Design of the European CLOSE Project”:
In the last 10 years tremendous progress has been made in the development of artificial pancreas (AP) systems for people with type 1 diabetes (T1D). The pan-European consortium CLOSE (Automated Glucose Control at Home for People with Chronic Disease) is aiming to develop integrated AP solutions (APplus) tailored to the needs of people with type 2 diabetes (T2D). APplus comprises a product and service package complementing the AP system by obligatory training as well as home visits and telemedical consultations on demand. Outcome predictors and performance indicators shall help to identify people who could benefit most from AP usage and facilitate the measurement of AP impact in diabetes care.
In a first step CLOSE will establish a scalable APplus model case working at the interface between patients, homecare service providers, and payers in France. CLOSE will then scale up APplus by pursuing geographic distribution, targeting additional audiences, and enhancing AP functionalities and interconnectedness. By being part of the European Institute of Innovation and Technology (EIT) Health public-private partnership, CLOSE is committed to the EIT “knowledge triangle” pursuing the integrated advancement of technology, education, and business creation. Putting stakeholders, education, and impact into the center of APplus advancement is considered key for achieving wide AP use in T2D care.
EIT Health helps Tubulis secure €10.7M in funding
Investor Network aids firm doing antibody work
EIT Health-backed start-ups garner big investments
A million each for iLoF and Restorative Neurotechnologies
EIT Health aids 11 start-ups disrupted by COVID-19
Start-up Rescue Instrument gives €5.5M in co-investment